AdvertisementInsurers And Government Are Slow To Cover Expensive CAR-T Cancer TherapyJuly 17, 2018Michelle AndrewsfacebookEmailSome critically ill patients who received a CAR-T cell treatment have remained cancer-free for as long as five years, researchers say. But the price is high. (Collection Mix: Subjects RF/Getty Images)